Publications: Dr Vijayabharathy Kanthasamy

Kanthasamy V ( 2025 ) . DEVELOPMENT AND VALIDATION OF A NEW DISEASE SPECIFIC QUALITY OF LIFE MEASURE FOR ATRIAL FIBRILLATION DERIVED FROM PATIENT PERSPECTIVES: THE ATRIAL FIBRILLATION PATIENT-REPORTED OUTCOME MEASURES (AF-PROMS) QUESTIONNAIRE . Postgraduate Medical Journal vol. 101 , ( Supplement_1 ) i3 - i3 .

Kanthasamy V, Schilling R, Horgan S, Baker V, Ahluwalia N, Hunter R, Hornarabashkh S, Finlay M ( 2025 ) . Development and validation of a new patient-centred quality of life measure for atrial fibrillation: the AF-PROM questionnaire . EP Europace vol. 27 , ( Supplement_1 )

Kanthasamy V, Finlay M, Earley M, Hunter RJ, Lim PB, Keene D, Whinnett Z, Mann I et al. ( 2025 ) . Safety and efficacy of catheter ablation for atrial fibrillation in an ambulatory day surgery center outside the hospital setting . Heart Rhythm vol. 22 , ( 8 ) 1935 - 1945 .

Kanthasamy V, Schilling RJ, Horan S, Baker V, Ahluwalia N, Hunter RJ, Honarbakhsh S, Finlay M ( 2025 ) . Development and validation of a new disease-specific quality-of-life measure for atrial fibrillation derived from patient perspectives: The Atrial Fibrillation Patient-Reported Outcome Measures (AF-PROMs) Questionnaire . Heart Rhythm vol. 22 , ( 8 ) 1922 - 1934 .

Kanthasamy V, Ang R, Sridhar A, Vyas S, Whittaker-Axon S, Schilling R, Honarbakhsh S, Papageorgiou N et al. ( 2025 ) . Subclavian Ansae Stimulation on Cardiac Hemodynamics and Electrophysiology in Atrial Fibrillation A Target for Sympathetic Neuromodulation . JACC Clinical Electrophysiology vol. 11 , ( 3 ) 563 - 578 .

Kanthasamy V, Schilling R, Zongo O, Khan K, Earley M, Monk V, Hunter R, Mangiafico V et al. ( 2024 ) . Objective randomised blinded investigation of therapeutic ablation versus cardioversion for persistent atrial fibrillation- outcomes of the feasibility . EP Europace vol. 26 , ( Supplement_1 )

Kanthasamy V, Ang R, Sridhar A, Vyas S, Schilling R, Honarbakhsh S, Ahluwalia N, Hunter R et al. ( 2024 ) . The influence of subclavian ansae stimulation on cardiac hemodynamics and electrophysiology in atrial fibrillation- exploring a novel target for neuromodulation in atrial fibrillation (SAS-AF study) . EP Europace vol. 26 , ( Supplement_1 )

Mahtani K, Maclean E, Parker M, Vyas R, Wang RB, Ahluwalia N, Kanthasamy V, Creta A et al. ( 2024 ) . Emergency pacemaker implantation in nonagenarians with CHB: single-versus dual-chamber pacing . British Journal of Cardiology vol. 31 , ( 2 )

Kanthasamy V, Schilling R, Zongo O, Khan K, Earley M, Monk V, Hunter R, Mangiafico V et al. ( 2023 ) . Feasibility of double-blinded, placebo-controlled interventional study for assessing catheter ablation efficacy in persistent atrial fibrillation: Insights from the ORBITA AF feasibility study . American Heart Journal vol. 269 , 56 - 71 .

Creta A, Ventrella N, Earley MJ, Finlay M, Sporton S, Maclean E, Kanthasamy V, Lemos Silva Di Nubila BC et al. ( 2023 ) . DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery A Multicenter Propensity-Matched Study . JACC Clinical Electrophysiology vol. 10 , ( 1 ) 121 - 132 .

Kanthasamy V, Breitenstein A, Schilling R, Hofer D, Tiongco B, Ang R, Hunter R, Earley M et al. ( 2023 ) . Catheter ablation of atrial fibrillation with a multi‐electrode radiofrequency balloon; first and early two centre experience in Europe . Journal of Cardiovascular Electrophysiology vol. 34 , ( 6 ) 1350 - 1359 .

Nikhil A ( 2022 ) . Long-Term Rhythm and Echocardiographic Outcomes of Patients with Heart Failure with Reduced Ejection Fraction After DC Cardioversion For for Atrial Fibrillation . Journal of Atrial Fibrillation and Electrophysiology vol. 15 , ( 6 )

Honarbakhsh S, Earley MJ, Martin CA, Creta A, Sohaib A, Ang R, Butcher C, Waddingham PH et al. ( 2022 ) . PolarX Cryoballoon metrics predicting successful pulmonary vein isolation: targets for ablation of atrial fibrillation . EP Europace vol. 24 , ( 9 ) 1420 - 1429 .

Breitenstein A, Kanthasamy V, Hofer D, Hunter R, Butcher C, Ahluwalia N, Schilling R, Finlay M ( 2022 ) . Early results of the novel radiofrequency balloon ablation catheter for pulmonary vein isolation . EP Europace vol. 24 , ( Supplement_1 )

Kanthasamy V, Papageorgiou N, Bajomo T, Monkhouse C, Creta A, Finlay M, Lambiase PD, Moore P et al. ( 2022 ) . Risk factors for developing pacing induced LV dysfunction: Experience from a tertiary center in the UK . Pacing and Clinical Electrophysiology vol. 45 , ( 3 ) 365 - 373 .

Breitenstein A, Kanthasamy V, Hofer D, Schilling RJ, Hunter RJ ( 2022 ) . Early results of the Heliostar™ RF balloon ablation catheter for pulmonary vein isolation . SWISS MEDICAL WEEKLY . vol. 152 , 51S - 51S .

Kanthasamy V ( 2021 ) . Incidence and Prognostic Impact of New-Onset Atrial Fibrillation in Patients with Severe Covid-19: A Retrospective Cohort Study . Journal of Atrial Fibrillation and Electrophysiology vol. 14 , ( 2 )

Kanthasamy V ( 2021 ) . Left atrial appendage occlusion: a niche procedure for a niche cohort? . European Heart Journal - Quality of Care and Clinical Outcomes vol. 7 , ( 5 ) 429 - 430 .

Wong G, Ahmed D, Creta A, Honarbakhsh S, Kanthasamy V, Hunter R, Schilling R ( 2021 ) . ProGlide venous closure device facilitates early ambulation following cryoablation of atrial fibrillation . EP Europace vol. 23 , ( Supplement_3 )

Creta A, Kanthasamy V, Schilling RJ, Rosengarten J, Khan F, Honarbakhsh S, Earley MJ, Hunter RJ et al. ( 2021 ) . First experience of POLARx™ versus Arctic Front Advance™: An early technology comparison . Journal of Cardiovascular Electrophysiology vol. 32 , ( 4 ) 925 - 930 .

Shurlock J, Rudd J, Jeanes A, Iacovidou A, Creta A, Kanthasamy V, Schilling R, Sullivan E et al. ( 2020 ) . Communication in the intensive care unit during COVID-19: early experience with the Nightingale Communication Method . International Journal for Quality in Health Care vol. 33 , ( 1 )

Kanthasamy V, Schilling RJ ( 2020 ) . Electrophysiology in the Era of Coronavirus Disease 2019 . Arrhythmia & Electrophysiology Review vol. 9 , ( 3 ) 167 - 170 .

Kanthasamy V, Schilling R . INCIDENCE AND PROGNOSTIC IMPACT OF NEW-ONSET ATRIAL FIBRILLATION IN PATIENTS WITH SEVERE COVID-19: A RETROSPECTIVE COHORT STUDY .